Daryl Jones

President & CEO

Daryl Jones
President & CEO

Mr. Jones has over 15 years of capital market experience and an established financial network. Prior to joining Isracann in 2018, Mr. Jones was an Investment advisor with PI Financial Corp Canada and Raymond James Ltd Canada. He was responsible for raising significant risk capital for growth companies in all sectors, with a particular focus on medical cannabis and natural resources. Mr. Jones took True Leaf Medicine public in early 2014 at $10MM valuation and exited in 2016 at $150MM market capitalization.

Stay up to date with IsraCann news & events